Abstract
Despite years of research, the pathophysiology of depression and the mechanism of action in antidepressant drugs largely remain unknown. The subsequent hypotheses examining depression witnessed attention being paid to the decrease of the serotonin and noradrenaline synaptic concentrations, adaptive changes in the neurotransmitters receptor, activation of the immune system, hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, and enhanced glutamatergic activity. Current research suggests that disturbed neuronal plasticity and the degeneration of neurons and glia cells may be involved in the pathogenesis of depression. In fact, in depressed patients, structural changes are observed in several brain regions, mainly in the hippocampus. Also, in various animal models of depression, morphological alteration in neurons and glial cells is present besides depression-like behavioral changes. A lot of evidence indicates that an increased amount or activity of glucocorticoids, glutamate, and proinflammatory cytokines is the reason for these changes. In both animal models of depression and postmortem studies, a reduced neurogenesis in the dentate gyrus of the hippocampus; a decrease in the total number of neurons and astrocytes; a reduction of the dendritic length, branching density, or the number of synapses; and a decrease in the brain-derived neurotrophic factor were observed. Moreover, activation of microglia, a source of proinflammatory cytokines and reactive oxygen species, has a disadvantageous effect on neurons and astrocytes. However, it should be noted that not all of the studies demonstrate neurodegenerative changes in depression, or the glucocorticoids’ detrimental action, so further studies are needed in order to clearly determine the contribution of neurotoxic agents in the pathogenesis of depression and also the importance of the neuroprotective properties of some antidepressant drugs in their therapeutic effect.
Abbreviations
- 5HT:
-
Serotonin
- ACTH:
-
Adrenocorticotropic hormone
- BDNF:
-
Brain-derived neurotrophic factor
- CMS:
-
Chronic mild stress
- CREB:
-
Cyclic AMP response element-binding protein
- CRF:
-
Corticotropin-releasing factor
- CRP:
-
C-reactive protein
- CUMS:
-
Chronic unpredictable mild stress
- CUS:
-
Chronic unpredictable stress
- GFAP:
-
Glial fibrillary acidic protein
- HPA:
-
Hypothalamic-pituitary-adrenal
- LPS:
-
Lipopolysaccharide
- MDD:
-
Major depressive disorder
- mPFC:
-
Medial prefrontal cortex
- NA:
-
Noradrenaline
- NLRP3:
-
Nod-like receptor protein 3
- NMDA:
-
N-methyl-D-aspartate
- NOS:
-
Nitric oxide synthase
- PFC:
-
Prefrontal cortex
- ROS:
-
Reactive oxygen species
- SNRI:
-
Selective noradrenaline reuptake inhibitors
- SSRI:
-
Selective serotonin reuptake inhibitors
- TCA:
-
Tricyclic antidepressant
References
Alcocer-Gómez, E., Casas-Barquero, N., Williams, M. R., Romero-Guillena, S. L., Cañadas-Lozano, D., Bullón, P., Sánchez-Alcazar, J. A., Navarro-Pando, J. M., & Cordero, M. D. (2017). Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in major depressive disorder. Pharmacological Research, 121, 114–121.
Alcocer-Gómez, E., de Miguel, M., Casas-Barquero, N., Núñez-Vasco, J., Sánchez-Alcazar, J. A., Fernández-Rodríguez, A., & Cordero, M. D. (2014). NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain, Behavior, and Immunity, 36, 111–117.
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P. F., Kavalali, E. T., & Monteggia, L. M. (2011). NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature, 475, 91–95.
Bachis, A., Cruz, M. I., Nosheny, R. L., & Mocchetti, I. (2008). Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex. Neuroscience Letters, 442, 104–108.
Baez, M., & Volosin, M. (1994). Corticosterone influence forced swim-induced immobility. Pharmacology, Biochemistry and Behavior, 49, 729–736.
Banasr, M., & Duman, R. S. (2008). Glial loss in the prefrontal cortex is sufficient to induce depressive- like behaviors. Biological Psychiatry, 64, 863–870.
Bartholomä, P., Erlandsson, N., Kaufmann, K., Rössler, O. G., Baumann, B., Wirth, T., Giehl, K. M., & Thiel, G. (2002). Neuronal cell death induced by antidepressants: Lack of correlation with Egr-1, NF-kB and extracellular signal-regulated protein kinase activation. Biochemical Pharmacology, 63, 1507–1516.
Bath, K. G., Jing, D. Q., Dincheva, I., Neeb, C. C., Pattwell, S. S., Chao, M. V., Lee, F. S., & Ninan, I. (2012). BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity. Neuropsychopharmacology, 37, 1297–1304.
Baumann, B., Bornschlegl, C., Krell, D., & Bogerts, B. (1997). Changes in CSF spaces differ in endogenous and neurotic depression a planimetric CT scan study. Journal of Affective Disor-ders, 45, 179–188.
Baxter, L. R., Jr., Phelps, M. E., Mazziotta, J. C., Schwartz, J. M., Selin, C. E., & Sumida, R. M. (1985). Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Archives of General Psychiatry, 42, 441–447.
Baxter, L. R., Jr., Schwartz, J. M., Phelps, M. E., Mazziotta, J. C., Guze, B. H., Selin, C. E., Gerner, R. H., & Sumida, R. M. (1989). Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry, 46, 243–250.
Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H. (2007). Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology, 32, 1888–1902.
Berton, O., & Nestler, E. J. (2006). New approaches to antidepressant drug discovery: Beyond monoamines. Nature Reviews Neuroscience, 7, 137–151.
Besedovsky, H. O., & del Ray, A. (1996). Immune-neuro-endocrine interactions: Facts and hypothesis. Endocrine Reviews, 17, 64–102.
Block, T. S., Kushner, H., Kalin, N., Nelson, C., Belanoff, J., & Schatzberg, A. (2018). Combined analysis of mifepristone for psychotic depression: Plasma levels associated with clinical response. Biological Psychiatry, 84, 46–54.
Boje, K. M., & Arora, P. K. (1992). Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Research, 587, 250–256.
Bremner, J. D., Vythilingam, M., Vermetten, E., Nazeer, A., Adil, J., Khan, S., Staib, L. H., & Charney, D. S. (2002). Reduced volume of orbitofrontal cortex in major depression. Biological Psychiatry, 51, 273–279.
Brown, G. W., & Harris, T. (1978). Social origin of depression: A study of psychiatric disorder in women. Tavistock.
Brown, E. S., Varghese, F. P., & McEwen, B. S. (2004). Association of depression with medical illness: Does cortisol play a role? Biological Psychiatry, 55, 1–9.
Caetano, S. C., Hatch, J. P., Brambilla, P., Sassi, R. B., Nicoletti, M., Mallinger, A. G., Frank, E., Kupfer, D. J., Keshavan, M. S., & Soares, J. C. (2004). Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Research, 132, 141–147.
Cai, W., Khaoustov, V. I., Xie, Q., Pan, T., Le, W., & Yoffe, B. (2005). Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. Journal of Hepatology, 42, 880–887.
Cameron, H. A., Tanapat, P., & Gould, E. (1998). Adrenal steroids and N-methyl-D-aspartate receptor activation regulate neurogenesis in the dentate gyrus of adult rats through a common pathway. Neuroscience, 82, 349–354.
Carroll, B. J. (1982). The dexamethasone suppression test for melancholia. British Journal of Psychiatry, 140, 292–304.
Castanon, N., Médina, C., Mormède, C., & Dantzer, R. (2004). Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats. Psychoneuroendocrinology, 29, 778–790.
Cerqueira, J. J., Catania, C., Sotiropoulos, I., Schubert, M., Kalish, R., Almeida, O. F. X., Auer, D. P., & Sousa, N. (2005). Corticosteroid status influences the volume of the rat cingulate cortex – A magnetic resonance imaging study. Journal of Psychiatric Research, 39, 451–460.
Charney, D. S., Menkes, D. B., & Heninger, G. R. (1981). Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Archives of General Psychiatry, 38, 1160–1180.
Chen, C. H., Ridler, K., Suckling, J., Williams, S., Fu, C. H., Merlo-Pich, E., & Bullmore, E. (2007). Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biological Psychiatry, 62, 407–414.
Coffey, C. E., Wilkinson, W. E., Weiner, R. D., Parashos, I. A., Djang, W. T., Webb, M. C., Figiel, G. S., & Spritzer, C. E. (1993). Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Archives of General Psychiatry, 50, 7–16.
Conti, P., Caraffa, A., Ronconi, G., Conti, C. M., Kritas, S. K., Mastrangelo, F., Tettamanti, L., & Theoharides, T. C. (2018). Impact of mast cells in depression disorder: Inhibitory effect of IL-37 (new frontiers). Immunologic Research, 66, 323–331.
Cotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001). Reduced glial cell density and neuronal volume in major depression in the anterior cingulate cortex. Archives of General Psychiatry, 58, 545–553.
Czéh, B., Michaelis, T., Watanabe, T., Frahm, J., de Biurrun, G., van Kampen, M., Bartolomucci, A., & Fuchs, E. (2001). Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proceedings of the National Academy of Sciences, 98, 12796–12801.
Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006). Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology, 31, 1616–1626.
Czéh, B., Welt, T., Fischer, A. K., Erhardt, A., Schmitt, W., M€uller, M. B., Toschi, N., Fuchs, E., & Keck, M. E. (2002). Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: Effects on stress hormone levels and adult hippocampal neurogenesis. Biological Psychiatry, 52, 1057–1065.
Dasari, M., Friedman, L., Jesberger, J., Stuve, T. A., Findling, F. L., Swales, T. P., & Schulz, S. C. (1999). A magnetic resonance imaging study of thalamic area in adolescent patients with either schizophrenia or bipolar disorder as compared to healthy controls. Psychiatry Research, 91, 155–162.
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005). Stress and the brain: From adaptation to disease. Nature Reviews Neuroscience, 6, 463–475.
Deschwanden, A., Karolewicz, B., Feyissa, A. M., Treyer, V., Ametamey, S. M., Johayem, A., Burger, C., Auberson, Y. P., Sovago, J., Stockmeier, C. A., Buck, A., & Hasler, G. (2011). Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C] ABP688 PET and postmortem study. American Journal of Psychiatry, 168, 727–734.
Detka, J., Kurek, A., Basta-Kaim, A., Kubera, M., Lasoń, W., & Budziszewska, B. (2013). Neuroendocrine link between stress, depression and diabetes. Pharmacological Reports, 65, 1591–1600.
Dhabhar, F. S., Burke, H. M., Epel, E. S., Mellon, S. H., Rosser, R., Reus, V. I., & Wolkowitz, O. M. (2009). Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 inadults with major depression. Journal of Psychiatric Research, 43, 962–969.
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctot, K. L. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67, 446–457.
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386, 824–827.
Duman, R. S. (2002). Pathophysiology of depression: The concept of synaptic plasticity. European Psychiatry, 17, 306–310.
Duman, R. S., Kodama, M., & Fujioka, T. (2004). Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biological Psychiatry, 56, 570–580.
Dunn, A. J., Wang, J., & Ando, T. (1999). Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Advances in Experimental Medicine and Biology, 46, 1117–1127.
Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindstrom, L. H., & Engberg, G. (2001). Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neuroscience Letters, 313, 96–98.
Esplugues, J. V. (2002). NO as a signalling molecule in the nervous system. British Journal of Pharmacology, 135, 1079–1095.
Feyissa, A. M., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2009). Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33, 70–75.
Finkel, M. S. (1996). Paroxetine is a novel nitric oxide synthase inhibitor. Psychopharmacology Bulletin, 32, 653–658.
Fox, M. E., & Lobo, M. K. (2019). The molecular and cellular mechanisms of depression: A focus on reward circuitry. Molecular Psychiatry, 24, 1798–1815.
Freis, E. (1954). Mental depression in hypertensives treated for long periods with large doses of reserpine. New England Journal of Medicine, 251, 1006–1008.
Frodl, T. S., Koutsouleris, N., Bottlender, R., Born, C., Jäger, M., Scupin, I., Reiser, M., Möller, H. J., & Meisenzahl, E. M. (2008). Depression-related variation in brain morphology over 3 years: Effects of stress? Archives of General Psychiatry, 65, 1156–1165.
Georgin-Lavialle, S., Moura, D. S., Salvador, A., Chauvet-Gelinier, J. C., Launay, J. M., Damaj, G., Côté, F., Soucié, E., Chandesris, M. O., Barète, S., Grandpeix-Guyodo, C., Bachmeyer, C., Alyanakian, M. A., Aouba, A., Lortholary, O., Dubreuil, P., Teyssier, J. R., Trojak, B., Haffen, E., Vandel, P., Bonin, B., French Mast Cell Study Group, Hermine, O., & Gaillard, R. (2016). Mast cells' involvement in inflammation pathways linked to depression: Evidence in mastocytosis. Molecular Psychiatry, 21, 1511–1516.
Gorman, J. M., & Docherty, J. P. (2010). A hypothesized role for dendritic remodeling in the etiology of mood and anxiety disorders. Journal of Neuropsychiatry and Clinical Neurosciences, 22, 256–264.
Gourley, S. L., Wu, F. J., Kiraly, D. D., Ploski, J. E., Kedves, A. T., Duman, R. S., & Taylor, J. R. (2007). Regionally specific regulation of ERK MAP kinase in a model of antidepressant – Sensitive chronic depression. Biological Psychiatry, 63, 353–359.
Grieve, S. M., Korgaonkar, M. S., Koslow, S. H., Gordon, E., & Williams, L. M. (2013). Widespread reductions in gray matter volume in depression. Neuroimage Clinical, 3, 332–339.
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001). Kynurenine pathway metabolism in human astrocytes: A paradox for neuronal protection. Journal of Neurochemistry, 78, 842–853.
Gunning, F. M., Cheng, J., Murphy, C. F., Kanellopoulos, D., Acuna, J., Hoptman, M. J., Klimstra, S., Morimoto, S., Weinberg, J., & Alexopoulos, G. S. (2009). Anterior cingulate cortical volumes and treatment remission of geriatric depression. International Journal of Geriatric Psychiatry, 24, 829–836.
Hannestad, J., Dellagioia, N., & Bloch, M. (2011). The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: A meta-analysis. Neuropsychopharmacology, 36, 2452–2459.
Hardingham, G. E., & Bading, H. (2010). Synaptic versus extrasynaptic NMDA receptor signaling; implications for neurodegenerative disorders. Nature Reviews Neuroscience, 11, 682–696.
Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., & Kanba, S. (2007). Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Experimental Neurology, 206, 33–42.
Hasler, G. (2010). Pathophysiology of depression: Do we have any solid evidence of interest to clinicians? World Psychiatry, 9, 155–161.
Hastings, R. S., Parsey, R. V., Oquendo, M. A., Arango, V., & Mann, J. (2004). Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsy-chopharmacology, 29, 952–959.
Hennings, J. M., Schaaf, L., & Fulda, S. (2012). Glucose metabolism and antidepressant medication. Current Pharmaceutical Design, 18, 5900–5919.
Herman, J. P., Figueiredo, H., Mueller, N. K., Ulrich-Lai, Y., Ostrander, M. M., Choi, D. C., & Cullinan, W. E. (2003). Central mechanisms of stress integration: Hierarchical circuitry control-ling hypothalamo-pituitary-adrenocortical responsiveness. Frontiers in Neuroendocrinology, 24, 151–180.
Hermine, O., Lortholary, O., Leventhal, P. S., Catteau, A., Soppelsa, F., Baude, C., Cohen-Akenine, A., Palmerini, F., Hanssens, K., Yang, Y., Sobol, H., Fraytag, S., Ghez, D., Suarez, F., Barete, S., Casassus, P., Sans, B., Arock, M., Kinet, J. P., Dubreuil, P., & Moussy, A. (2008). Case-control cohort study of patients' perceptions of disability in mastocytosis. PLoS One, 3, e2266.
Holsboer, F. (1999). The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. Journal of Psychiatric Research, 33, 181–214.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine, 71, 171–186.
Hwang, J., Zheng, L. T., Ock, J., Lee, M. G., Kim, S. H., Lee, H. W., Lee, W. H., Park, H. C., & Suk, K. (2008). Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology, 55, 826–834.
Iwata, M., Ota, K. T., & Duman, R. S. (2013). The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses. Brain, Behavior, and Immunity, 31, 105–114.
Jaako-Movits, K., Zharkovsky, T., Pedersen, M., & Zharkovsky, A. (2006). Decreased hippocampal neurogenesis following olfactory bulbectomy is reversed by repeated citalopram admin- istration. Cellular and Molecular Neurobiology, 26, 1559–1570.
Jayatissa, M. N., Bisgaard, C., Tingström, A., Papp, M., & Wiborg, O. (2006). Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology, 31, 2395–2404.
Joca, S. R., & Guimarăes, F. S. (2006). Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology, 185, 298–305.
Johansen-Berg, H., Gutman, D. A., Behrens, T. E., Matthews, P. M., Rushworth, M. F., Katz, E., Lozano, A. M., & Mayberg, H. S. (2008). Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cerebral Cortex, 18, 1374–1383.
Karolewicz, B., Feyissa, A. M., Chandran, A., Legutko, B., Ordway, G. A., Rajkowska, G., & Stockmeier, C. A. (2009). Glutamate receptors expression in postmortem brain from depressed subjects. Biological Psychiatry, 65, 177S.
Kawasaki, H., Chang, H. W., Tseng, H. C., Hsu, S. C., Yang, S. J., Hung, C. H., Zhou, Y., & Huang, S. K. (2014). A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor. Allergy, 69, 445–452.
Kellner, C. H., Rubinow, D. R., & Post, R. M. (1986). Cerebral ventricular size and cognitive impairment in depression. Journal of Affective Disorders, 10, 215–219.
Kennedy, S. H., Konarski, J. Z., Segal, Z. V., Lau, M. A., Bieling, P. J., McIntyre, R. S., & Mayberg, H. S. (2007). Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. American Journal of Psychiatry, 164, 778–788.
Kent, S., Rodriguez, F., Kelley, K. W., & Dantzer, R. (1994). Reduction in food and water intake induced by microinjection of interleukin-1b in the ventromedial hypothalamus of the rat. Physiology and Behavior, 56, 1031–1036.
Kim, J. S., Schmid-Burgk, W., Claus, D., & Kornhuber, H. H. (1982). Increased serum glutamate in depressed patients. Archives of Psychiatry and Neurological Sciences, 232, 299–304.
Kitagami, T., Yamada, K., Miura, H., Hashimoto, R., Nabeshima, T., & Ohta, T. (2003). Mech-anism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: Role of nitric oxide as a signal crossing the blood–brain barrier. Brain Research, 978, 104–114.
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014). Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry, 71, 1381–1391.
Kole, M. H. P., Swan, L., & Fuchs, E. (2002). The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. European Journal of Neuroscience, 16, 807–816.
Korgaonkar, M. S., Fornito, A., Williams, L. M., & Grieve, S. M. (2014). Abnormal structural networks characterize major depressive disorder: A connectome analysis. Biological Psychiatry, 76, 567–574.
Kosten, T. A., Galloway, M. P., Duman, R. S., Russell, D. S., & D’Sa, C. (2008). Repeated unpredictable stress and antidepressants differentially regulate expression of the Bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychophar-macology, 33, 1545–1558.
Krohn, K., Rozovsky, I., Wals, P., Teter, B., Anderson, C. P., & Finch, C. E. (1999). Glial fibrillary acidic protein transcription responses to transforming growth factor-b1 and interleukin-1b are mediated by a nuclear factor-1-like site in the near-upstream promoter. Journal of Neurochemistry, 72, 1353–1361.
Kronfol, Z. (2002). Immune dysregulation in major depression: A critical review of existing evidence. International Journal of Neuropsychopharmacology, 5, 333–343.
Lacerda, A. L. T., Keshavan, M. S., Hardan, A. Y., Yorbik, O., Brambilla, P., Sassi, R. B., Nicoletti, M. A., Mallinger, A. G., Frank, E., Kupfer, D. J., & Soares, J. C. (2004). Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biological Psychiatry, 55, 353–358.
Laping, N. J., Teter, B., Nichols, N. R., Rozovbsky, I., & Finch, C. E. (1994). Glial fibrillary acidic protein: Regulation by hormones, cytokines and growth factors. Brain Pathology, 1, 259–275.
Lee, H. J., Kim, J. W., Yim, S. V., Kim, M. J., Kim, S. A., Kim, Y. J., Kim, C. J., & Chung, J. H. (2001). Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats. Molecular Psychiatry, 6, 725–728.
Lemaire, V., Koehl, M., Le Moal, M., & Abrous, D. N. (2000). Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proceedings of the National Academy of Sciences of the United States of America, 97, 11032–11037.
Levine, J., Panchalingam, K., Rapoport, A., Gershon, S., McClure, R. J., & Pettegrew, J. W. (2000). Increased cerebrospinal fluid glutamine levels in depressed patients. Biological Psychiatry, 47, 586–593.
Li, H., & Poulos, T. L. (2005). Structure-function studies on nitric oxide synthases. Journal of Inorganic Biochemistry, 99, 293–305.
Liotti, M., Mayberg, H. S., McGinnis, S., Brannan, S. L., & Jerabek, P. (2002). Unmasking disease-specific cerebral blood flow abnormalities: Mood challenge in patients with remitted unipolar depression. American Journal of Psychiatry, 159, 1830–1840.
Liu, B., & Hong, J. S. (2003). Role of microglia in inflammation-mediated neurodegenerative diseases:Mechanisms and strategies for therapeutic intervention. Journal of Pharmacology and Experimental Therapeutics, 304, 1–7.
Lucassen, P. J., Vollmann-Honsdorf, G. K., Gleisberg, M., Czéh, B., De Kloet, E. R., & Fuchs, E. (2001). Chronic psychosocial stress differentially affects apoptosis in hippo- campal subregions and cortex of the adult tree shrew. European Journal of Neuroscience, 14, 161–166.
MacMillan, S., Szeszko, P. R., Moore, G. J., Madden, R., Lorch, E., Ivey, J., Banerjee, S. P., & Rosenberg, D. R. (2003). Increased amygdala: Hippocampal volume ratios associated with severity of anxiety in pediatric major depression. Journal of Child and Adolescent Psychopharmacology, 13, 65–73.
MacQueen, G. M., Campbell, S., McEwen, B. S., MacDonald, K., Amano, S., Joffe, R. T., Nahmias, C., & Young, L. T. (2003). Course of illness, hippocampal function, and. Hippocampal volume in major depression. Proceedings of the National Academy of Sciences of the United States of America, 3, 1387–1392.
Madsen, T. M., Greisen, M. H., Nielsen, S. M., Bolwig, T. G., & Mikkelsen, J. D. (2000). Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus. Neuroscience, 98, 33–39.
Maes, M., D’Haese, P. C., Scharpé, S., D’Hondt, P., Cosyns, P., & De Broe, M. E. (1994). Hypozincemia in depression. Journal of Affective Disorders, 31, 135–140.
Magarinos, A. M., & McEwen, B. S. (1995). Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience, 69, 89–98.
Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000). Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biological Psychiatry, 48, 830–843.
McEwen, B. S. (1999). Stress and hippocampal plasticity. Annual Review of Neuroscience, 22, 105–122.
McEwen, B. S., & Chattarji, S. (2004). Molecular mechanisms of neuroplasticity and pharmaco-logical implications: The example of tianeptine. European Neuropsychopharmacology, 14, 497–502.
Miller, A. H., Maletic, V., & Raison, C. L. (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65, 732–741.
Miller, O. H., Moran, J. T., & Hall, B. J. (2016). Two cellular hypotheses explaining the initiation of ketamine’s antidepressant actions: Direct inhibition and disinhibition. Neuropharmacology, 100, 17–26.
Mitani, H., Shirayama, Y., Yamada, T., Maeda, K., Ashby, C. R., Jr., & Kawahara, R. (2006). Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 1155–1158.
Młyniec, K., Gaweł, M., & Nowak, G. (2015). Study of antidepressant drugs in GPR39 (zinc receptor−/−) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists. Behavioural Brain Research, 287, 135–138.
Moron, J. A., Zakharova, I., Ferrer, J. V., Merrill, G. A., Hope, B., Lafer, E. M., Lin, Z. C., Wang, J. B., Javitch, J. A., Galli, A., & Shippenberg, T. S. (2003). Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. Journal of Neuroscience, 23, 8480–8488.
Moura, D. S., Sultan, S., Georgin-Lavialle, S., Pillet, N., Montestruc, F., Gineste, P., Barete, S., Damaj, G., Moussy, A., Lortholary, O., & Hermine, O. (2011). Depression in patients with mastocytosis: Prevalence, features and effects of masitinib therapy. PLoS One, 6, e26375.
Murmu, M. S., Salomon, S., Biala, Y., Weinstock, M., Braun, K., & Bock, J. (2006). Changes of spine density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to stress during pregnancy. European Journal of Neuroscience, 24, 1477–1487.
Musazzi, L., Treccani, G., & Popoli, M. (2015). Functional and structural remodeling of glutamate synapses in prefrontal and frontal cortex induced by behavioral stress. Frontiers in Psychiatry, 6, 60.
Myint, A. M., O’Mahony, S., Kubera, M., Kim, Y. K., Kenny, C., Kaim-Basta, A., Steinbusch, H. W., & Leonard, B. E. (2007). Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats. Psychopharmacology, 21, 843–850.
Nair, A., & Bonneau, R. H. (2006). Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. Journal of Neuroimmunology, 171, 72–85.
Nemeroff, C. B., & Owens, M. J. (2002). Treatment of mood disorders. Nature Neuroscience, 5, 1068–1070.
Nibuya, M., Morinobu, S., & Duman, R. S. (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience, 15, 7539–7547.
Nibuya, M., Nestler, E. J., & Duman, R. S. (1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. Journal of Neuroscience, 16, 2365–2372.
Nowak, G., Ordway, G. A., & Paul, I. A. (1995). Alterations in the N-methyl-D-aspartate receptor complex in the frontal cortex of suicide victims. Brain Research, 675, 157–164.
Nowak, B., Zadrozna, M., Ossowska, G., Sowa-Kućma, M., Gruca, P., Papp, M., Dybała, M., Pilc, A., & Nowak, G. (2010). Alterations in hippocampal calcium binding neurons induced by stress models of depression. Preliminary assessment. Pharmacological Reports, 62, 1204–1210.
Nudmamud-Thanoi, S., & Reynolds, G. P. (2004). The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders. Neuroscience Letters, 372, 173–177.
O’Sullivan, J. B., Ryan, K. M., Curtin, N. M., Harkin, A., & Connor, T. J. (2009). Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: Implications for depression and neurodegeneration. The International Journal of Neuropsychopharmacology, 12, 687–699.
Ohira, K., Hagihara, H., Miwa, M., Nakamura, K., & Miyakawa, T. (2019). Fluoxetine-induced dematuration of hippocampal neurons and adult cortical neurogenesis in the common marmoset. Molecular Brain, 12, 69.
Oliveira, R. M., Guimarăes, F. S., & Deakin, J. F. (2008). Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Brazilian Journal of Medical and Biological Research, 41, 333–341.
Ongur, D., Drevets, W. C., & Price, J. L. (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America, 95, 13290–13295.
Osuch, E. A., Ketter, T. A., Kimbrell, T. A., George, M. S., Benson, B. E., Willis, M. W., Herscovitch, P., & Post, R. M. (2000). Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biological Psychiatry, 48, 1020–1023.
Ozcan, H., Aydın, N., Aydın, M. D., Oral, E., Gündoğdu, C., Şipal, S., & Halıcı, Z. (2020). Olfactory bulbectomy and raphe nucleus relationship: A new vision for well-known depression model. Nordic Journal of Psychiatry, 74, 194–200.
Pariante, C. M., Pearce, B. D., Pisell, T. L., Sanchez, C. I., Po, C., Su, C., & Miller, A. H. (1999). The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor transloca- tion and function. Endocrinology, 140, 4359–4366.
Parker, K. J., Schatzberg, A. F., & Lyons, D. M. (2003). Neuroendocrine aspects of hypercor- tisolism in major depression. Hormones and Behavior, 43, 60–66.
Pei, Z., Pang, H., Qian, L., Yang, S., Wang, T., Zhang, W., Wu, X., Dallas, S., Wilson, B., Reece, J. M., Miller, D. S., Hong, J. S., & Block, M. L. (2007). MAC1 mediates LPS-induced production of superoxide by microglia: The role of pattern recognition receptors in dopaminergic neurotoxicity. Glia, 55, 1362–1373.
Petrilli, M. A., Kranz, T. M., Kleinhaus, K., Joe, P., Getz, M., Johnson, P., Chao, M. V., & Malaspina, D. (2017). The emerging role for zinc in depression and psychosis. Frontiers in Pharmacology., 8, 414.
Pham, K., Nacher, J., Hof, P. R., & McEwen, B. S. (2003). Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. European Journal of Neuroscience, 17, 879–886.
Phan, K. L., Wager, T., Taylor, S. F., & Liberzon, I. (2002). Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI. NeuroImage, 16, 331–348.
Pittenger, C., & Duman, R. S. (2008). Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology, 33, 88–109.
Prakash, A., Bharti, K., & Majeed, A. B. (2015). Zinc: Indications in brain disorders. Fundamental & Clinical Pharmacology, 29, 131–149.
Price, J. L., & Drevets, W. C. (2010). Neurocircuitry of mood disorders. Neuropsychophar-macology, 35, 192–216.
Qiao, H., An, S. C., Xu, C., & Ma, X. M. (2017). Role of proBDNF and BDNF in dendritic spine plasticity and depressive-like behaviors induced by an animal model of depression. Brain Research, 1663, 29–37.
Qiao, H., Li, M. X., Xu, C., Chen, H. B., An, S. C., & Ma, X. M. (2016). Dendritic spines in depression: What we learned from animal models. Neural Plasticity, 2016, 8056370.
Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010). CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: Relationship to CNS immune responses and depression. Molecular Psychiatry, 15, 393–403.
Rajkowska, G. (2000). Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biological Psychiatry, 48, 766–777.
Rajkowska, G., & Miguel-Hidalgo, J. J. (2007). Gliogenesis and glial pathology in depression. CNS and Neurological Disorders – Drug Targets, 6, 219–233.
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999). Morphometric evidence for neuronal and glial prefrontal pathology in major depression. Biological Psychiatry, 45, 1085–1098.
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001). Cytokine-associated emotional and cognitive disturbances in humans. Archives of General Psychiatry, 58, 445–452.
Roy, T., & Lloyd, C. E. (2012). Epidemiology of depression and diabetes: A systematic review. Journal of Affective Disorders, 142, S8–S21.
Ruhé, H. G., Mason, N. S., & Schene, A. H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies. Molecular Psychiatry, 12, 331–359.
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., Ernfors, P., & Castrén, E. (2003). Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant- induced behavioral effects. Journal of Neuroscience, 23, 349–357.
Sapolsky, R. M., Krey, L. C., & McEwen, B. S. (1986). The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocrine Reviews, 7, 284–301.
Schwarcz, R., & Pellicciari, R. (2002). Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities. Journal of Pharmacology and Experimental Therapeutics, 303, 1–10.
Serra-Millàs, M., López-Vílchez, I., Navarro, V., Galán, A. M., Escolar, G., Penadés, R., Catalán, R., Fañanás, L., Arias, B., & Gastó, C. (2011). Changes in plasma and platelet BDNF levels induced by S-Citalopram in major depression. Psychopharmacology, 216, 1–8.
Shah, P. J., Glabus, M. F., Goodwin, G. M., & Ebmeier, K. P. (2002). Chronic, treatment resistant depression and right fronto-striatal atrophy. British Journal of Psychiatry, 180, 434–440.
Sheline, Y. I., Gado, M. H., & Price, J. L. (1998). Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport, 9, 2023–2028.
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S., & Iyo, M. (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry, 54, 70–75.
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience, 22, 3251–3261.
Singh, M. K., Leslie, S. M., Packer, M. M., Zaiko, Y. V., Phillips, O. R., Weisman, E., Wall, D., Jo, B., & Rasgon, N. L. (2019). Brain and behavioral correlates of insulin resistance in youth with depression and obesity. Hormones and Behavior, 108, 73–83.
Siwek, M., Dudek, D., Paul, I. A., Sowa-Kućma, M., Zieba, A., Popik, P., Pilc, A., & Nowak, G. (2009). Zinc supplementation augments efficacy of imipramine in treatment resistant patients: A double blind, placebo-controlled study. Journal of Affective Disorders, 118, 187–195.
Skolnick, P., Layer, R. T., Popik, P., Nowak, G., Paul, I. A., & Trullas, R. (1996). Adaptation of N-methyl-D-aspartate receptors following antidepressant treatment: Implications for the phar-macotherapy of depression. Pharmacopsychiatry, 29, 23–26.
Sonino, N., Fava, G. A., Belluardo, P., Girelli, M. E., & Boscaro, M. (1993). Course of depression in Cushing’s syndrome: Response to treatment and comparison with graves’ disease. Hormone Research, 39, 202–206.
Sorra, K. E., & Harris, K. M. (2000). Overview on the structure, composition, function, development, and plasticity of hippocampal dendritic spines. Hippocampus, 10, 501–511.
Sousa, N., Lukoyanov, N. V., Madeira, M. D., Almeida, O. F., & Paula-Barbosa, M. M. (2000). Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience, 97, 253–266.
Southam, E., & Garthwaite, J. (1993). The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology, 32, 1267–1277.
Španová, A., Kovářů, H., Lisá, V., Lukásová, E., & Rittich, B. (1997). Estimation of apoptosis in C6 glioma cells treated with antidepressants. Physiological Research, 46, 161–164.
Steiner, J., Bogerts, B., Sarnyai, Z., Walter, M., Gos, T., Bernstein, H. G., & Myint, A. M. (2011). Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity. World Journal of Biological Psychiatry, 13(7), 482–492.
Stockmeier, C. A., Mahajan, G. J., Konick, L. C., Overholser, J. C., Jurjus, G. J., Meltzer, H. Y., Uylings, H. B. M., Friedman, L., & Rajkowska, G. (2004). Cellular changes in the postmortem hippocampus in major depression. Biological Psychiatry, 56, 640–650.
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015). Inflammation andclinical response to treatment in depression: A meta-analysis. European Neuropsychopharmacology, 25, 1532–1543.
Szewczyk, B., Kubera, M., & Nowak, G. (2011). The role of zinc in neurodegenerative inflammatory pathways in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 693–701.
Szewczyk, B., Poleszak, E., Pilc, A., & Nowak, G. (2010). Ionic glutamate modulators in depression (zinc, magnesium). In P. Skolnick (Ed.), Glutamate-based therapies for psychiatric disorders (M. J Parnham & J. Bruinvels (Series Eds.), Milestones in drug therapy; pp. 21–38), Springer.
Trullas, R., & Skolnick, P. (1990). Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. European Journal of Pharmacology, 185, 1–10.
Tsopelas, C., Stewart, R., Savva, G. M., Brayne, C., Ince, P., Thomas, A., & Matthews, F. E. (2011). Neuropathological correlates of late-life depression in older people. The British Journal of Psychiatry, 198, 109–114.
Turchan-Cholewo, J., Dimayuga, F. O., Gupta, S., Keller, J. N., Knapp, P. E., Hauser, K. F., & Bruce-Keller, A. J. (2009). Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: Possible role in cytokine regulation. Journal of Neurochemistry, 108, 202–215.
Tynan, R. J., Weidenhofer, J., Hinwood, M., Cairns, M. J., Day, T. A., & Walker, F. R. (2012). A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain, Behavior, and Immunity, 26, 469–479.
Valentine, A. D., Meyers, C. A., Kling, M. A., Richelson, E., & Hauser, P. (1998). Mood and cognitive side-effects of interferon-a therapy. Seminars in Oncology, 25, 39–47.
Van Craenenbroeck, K., De Bosscher, K., Vanden Berghe, W., Vanhoenacker, P., & Haegeman, G. (2005). Role of glucocorticoids in dopamine-related neuropsychiatric disorders. Molecular and Cellular Endocrinology, 245, 10–22.
Vollmayr, B., Simonis, C., Weber, S., Gass, P., & Henn, F. (2003). Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biological Psychiatry, 54, 1035–1040.
Wang, T., Pei, Z., Zhang, W., Liu, B., Langenbach, R., Lee, C., Wilson, B., Reece, J. M., Miller, D. S., & Hong, J. S. (2005). MPP+ induced COX-2 activation and subsequent dopaminergic neurodegeneration. FASEB Journal, 19, 1134–1136.
Watanabe, Y., Gould, E., & McEwen, B. S. (1992). Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Research, 588, 341–345.
Wellman, C. L. (2001). Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. Journal of Neurobiology, 49, 245–253.
Weniger, G., Lange, C., & Irle, E. (2006). Abnormal size of the amygdala predicts impaired emotional memory in major depressive disorder. Journal of Affective Disorders, 94, 219–229.
Wu, C. W., Chen, Y. C., Yu, L., Chen, H. I., Jen, C. J., Huang, A. M., Tsai, H. J., Chang, Y. T., & Kuo, Y. M. (2007). Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory. Journal of Neu-rochemistry, 103, 2471–2481.
Zanos, P., & Gould, T. D. (2018). Mechanisms of ketamine action as an antidepressant. Molecular Psychiatry, 23, 801–811.
Zhang, Y., Gu, F., Chen, J., & Dong, W. (2010). Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Research, 1366, 141–148.
Zhang, Y., Liu, L., Liu, Y.-Z., Shen, X.-L., Wu, T.-Y., Zhang, T., Wang, W., Wang, Y.-X., & Jiang, C.-L. (2015). NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation. International Journal of Neuropsychopharmacology, 18, 1–8.
Zhang, Y., Yu, C., Zhou, Y., Li, K., Li, C., & Jiang, T. (2009). Decreased gyrification in major depressive disorder. Neuroreport, 20, 378–380.
Zobel, A. W., Nickel, T., Kunzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000). Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated. Journal of Psychiatric Research, 34, 171–181.
Zunszain, P. A., Anacker, C., Cattaneo, A., Choudhury, S., Musaelyan, K., Myint, A. M., Thuret, S., Price, J., & Pariante, C. M. (2012). Interleukin-1b: A new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology, 37, 939–949.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Smaga, I. et al. (2021). Neurotoxicity in Depression. In: Kostrzewa, R.M. (eds) Handbook of Neurotoxicity. Springer, Cham. https://doi.org/10.1007/978-3-030-71519-9_176-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-71519-9_176-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71519-9
Online ISBN: 978-3-030-71519-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences